{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:47:08Z","timestamp":1764510428347},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ejim.2012.01.012","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T05:27:17Z","timestamp":1331011637000},"page":"368-373","source":"Crossref","is-referenced-by-count":15,"title":["Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma"],"prefix":"10.1016","volume":"23","author":[{"given":"G.","family":"Tsirakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Spanoudakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chochlakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alegakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.E.","family":"Psarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stratinaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.N.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Alexandrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.01.012_bb0005","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis","volume":"333","author":"Folkman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2012.01.012_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2012.01.012_bb0020","first-page":"800","article-title":"Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheralblood","volume":"85","author":"Di Raimondo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2012.01.012_bb0025","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1515\/CCLM.2004.230","article-title":"Bone marrow microvascular density and angiogenic growth factors in multiple myeloma","volume":"42","author":"Alexandrakis","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ejim.2012.01.012_bb0030","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejim.2012.01.012_bb0035","first-page":"524","article-title":"Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin","volume":"7","author":"Takahashi","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejim.2012.01.012_bb0040","doi-asserted-by":"crossref","first-page":"43799","DOI":"10.1074\/jbc.M207160200","article-title":"Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways","volume":"277","author":"S\u00e1nchez-Elsner","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2012.01.012_bb0045","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","article-title":"CD105 is important for angiogenesis: evidence and potential applications","volume":"17","author":"Duff","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.ejim.2012.01.012_bb0050","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","article-title":"Endoglin is a component of the transforming growth factor-beta receptor system in human endothelialcells","volume":"267","author":"Cheifetz","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2012.01.012_bb0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V87.5.1928.1928","article-title":"Transforming growth factor-beta1: differential effects on multiple myeloma versusnormal B cells","volume":"87","author":"Urashima","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2012.01.012_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000057358","article-title":"Molecular and cell biology of TGF-beta","volume":"24","author":"Roberts","year":"1998","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.ejim.2012.01.012_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ejim.2012.01.012_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<122::AID-IJC4>3.0.CO;2-M","article-title":"Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer","volume":"89","author":"Li","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejim.2012.01.012_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcp.10200","article-title":"Differential levels of soluble endoglin (CD105) in myeloid malignancies","volume":"194","author":"Calabr\u00f2","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.1095","article-title":"Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic,prognostic, and bioimmunotherapeutic potential in human malignancies","volume":"188","author":"Fonsatti","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2012.01.012_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(94)90228-3","article-title":"Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA","volume":"171","author":"Wang","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejim.2012.01.012_bb0095","first-page":"1623","article-title":"Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy","volume":"1","author":"Burrows","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejim.2012.01.012_bb0100","first-page":"3621","article-title":"Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization","volume":"18","author":"Bodey","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejim.2012.01.012_bb0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/86.5.386","article-title":"Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers","volume":"86","author":"Wang","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejim.2012.01.012_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D","article-title":"Tumoural vascularity as a prognostic factor in cancer patients: the evidencecontinues to grow","volume":"184","author":"Weidner","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0115","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2012.01.012_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64511-7","article-title":"Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity","volume":"157","author":"Lundberg","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0125","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10735-004-2341-0","article-title":"Expression of the proliferation-associated nuclear protein MIB-1 and its relationshipwith microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes","volume":"35","author":"Alexandrakis","year":"2004","journal-title":"J Mol Histol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-540-85772-3_4","article-title":"Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells","volume":"183","author":"Vacca","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ejim.2012.01.012_bb0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/cncr.11137","article-title":"Moving disease biology from the lab to the clinic","volume":"97","author":"Anderson","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2012.01.012_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2002.03654.x","article-title":"Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients","volume":"118","author":"Pruneri","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1096\/fasebj.14.1.55","article-title":"CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells","volume":"14","author":"Li","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.ejim.2012.01.012_bb0150","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood-2004-06-2101","article-title":"Circulating endothelialprogenitor cells in multiple myeloma: implications and significance","volume":"105","author":"Zhang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2012.01.012_bb0155","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1309\/X6NXYE57DLUE2NQ8","article-title":"Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma","volume":"127","author":"El-Gohary","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.prp.2010.05.015","article-title":"Endoglin (CD105) expression and angiogenesis status in small cell lung cancer","volume":"206","author":"Takase","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ejim.2012.01.012_bb0165","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/sj.bjc.6600874","article-title":"Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis","volume":"88","author":"Li","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2012.01.012_bb0170","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.11072","article-title":"A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications","volume":"97","author":"Lauta","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejim.2012.01.012_bb0175","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelialgrowth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2012.01.012_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sonc.2002.34072","article-title":"Moving disease biology from the laboratory to the clinic","volume":"29","author":"Anderson","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/10428199409059598","article-title":"Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index","volume":"12","author":"Thaler","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejim.2012.01.012_bb0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF02982813","article-title":"Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial","volume":"76","author":"Oh","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejim.2012.01.012_bb0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.2002.03871.x","article-title":"Bone marrow angiogenesis in multiple myeloma: effect of therapy","volume":"119","author":"Kumar","year":"2002","journal-title":"Br J Haematol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620512000362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T14:39:10Z","timestamp":1641047950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620512000362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0953620512000362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.01.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}